Wish to keep on high of the science and politics driving biotech right this moment? Enroll to get our biotech publication in your inbox.
Most cancers researchers have found {that a} infamous oncogene could sometimes wind up uncovered on the surface of tumor cells, hinting at a shocking new immunotherapy goal.
In the meantime, Trump continues to win the messaging battle on drug pricing, and biotech’s social circles get awkward once more with an Epstein-linked investor’s return.
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.
Have already got an account? Log in
View All Plans
